Under Development JAK Inhibitors for Dermatologic Diseases

Molecular targeting therapies represent a new exciting era in dermatology. A promising novel drug class, subject of intense research, is Janus kinase (JAK) inhibitors. Multiple cytokine receptors signal through the Janus kinase and signal transducer and activator of transcription (STAT) pathway. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Sideris, Nikolaos, Vakirlis, Efstratios, Tsentemeidou, Aikaterini, Kourouklidou, Alexandra, Ioannides, Demetrios, Sotiriou, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361191/
https://www.ncbi.nlm.nih.gov/pubmed/32676572
http://dx.doi.org/10.31138/mjr.31.1.137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361191/
https://www.ncbi.nlm.nih.gov/pubmed/32676572
http://dx.doi.org/10.31138/mjr.31.1.137

Ejemplares similares